FOG PHARMACEUTICALS, INC.

Profile

Company Names

FOG PHARMACEUTICALS, INC.

Addresses

30 ACORN PARK DRIVE, 6TH FLOOR, CAMBRIDGE, MA 02140

100 ACORN PARK, 6TH FLOOR, CAMBRIDGE, MA 02140

100 ACORN PARK DRIVE, 6TH FLOOR, CAMBRIDGE, MA 02140

245 FIRST STREET, 18TH FLOOR, BOSTON, MA 02142

20 ROWES WHARF, SUITE 410, BOSTON, MA 02110

Phone Numbers

617-945-9510
781-929-9187

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$278,410,908.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2022-11-17 
$177,999,922.00 
$177,999,922.00 
$0.00 
Equity 
4
2020-12-22 
$23,271,035.00 
$107,000,017.00 
$83,728,982.00 
Equity 
3
2018-02-02 
$65,514,944.00 
$66,014,944.00 
$500,000.00 
Equity 
2
2016-05-25 
$11,000,007.00 
$11,000,007.00 
$0.00 
Equity 
1
2015-11-02 
$625,000.00 
INDEFINITE 
INDEFINITE 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
 
ACETI 
EXECUTIVE OFFICER
ALZHEON, INC.   |  FOG PHARMACEUTICALS, INC.   |  THEROPTIX, INC.   |  EPOCH BIOTECH, LLC   |  X1 BIOTECH INC.
LEON 
 
CHEN 
DIRECTOR
TIFFS TREATS HOLDINGS INC   |  PARTSCHANNEL INVESTORS, INC.   |  TIFF-S TREATS HOUSTON LTD.   |  TIFF-S TREATS ATX 2 LTD.   |  GENOCEA BIOSCIENCES, INC.   |  CRESCENDO BIOSCIENCE, INC.   |  TIFF-S TREATS HOLDINGS, INC.   |  E-SCAPE BIO, INC.   |  RFXCEL CORP   |  LOGICBIO THERAPEUTICS, INC.   |  FOG PHARMACEUTICALS, INC.   |  NATURAL PARTNERS, INC   |  NURIX THERAPEUTICS, INC.   |  TIFF-S TREATS RALEIGH LTD.   |  TIFF-S TREATS GP OKLAHOMA, LLC   |  TIFF-S TREATS OKLAHOMA LTD.   |  TIFF-S TREATS TAMPA, LTD.   |  TIFF-S TREATS DENVER LTD.   |  EIKON THERAPEUTICS, INC.   |  SERANOVA BIO, INC.   |  PLEXIUM, INC.
EDWARD 
 
FITZGERALD 
DIRECTOR
EXETER/PHOENIX CO-INVESTMENT FUND, LP   |  FOG PHARMACEUTICALS, INC.
EDWARD 
M 
FITZGERALD 
DIRECTOR
FOG PHARMACEUTICALS, INC.
EDWARD 
M. 
FITZGERALD 
DIRECTOR
FOG PHARMACEUTICALS, INC.
COREY 
S. 
GOODMAN 
DIRECTOR
LIMERICK BIOPHARMA INC   |  IPIERIAN, INC.   |  FOG PHARMACEUTICALS, INC.
RICK 
 
KLAUSNER 
DIRECTOR
3-V BIOSCIENCES, INC.   |  PATHWORK DIAGNOSTICS INC   |  JUNO THERAPEUTICS, INC.   |  FOG PHARMACEUTICALS, INC.
JEFFREY 
A 
LEERINK 
DIRECTOR
FOG PHARMACEUTICALS, INC.
JEFFREY 
A. 
LEERINK 
DIRECTOR
LEERINK SWANN CO-INVESTMENT FUND, LLC   |  LEERINK TRANSFORMATION FUND I L.P.   |  MASSACHUSETTS INNOVATION CATALYST FUND I L.P.   |  LEERINK TRANSFORMATION PARTNERS STRATEGIC FUND L.P.   |  FOG PHARMACEUTICALS, INC.
GREGORY 
L 
VERDINE 
EXECUTIVE OFFICER, DIRECTOR
FOG PHARMACEUTICALS, INC.
GREGORY 
L. 
VERDINE 
EXECUTIVE OFFICER, DIRECTOR
WAVE LIFE SCIENCES PTE LTD   |  LIFEMINE THERAPEUTICS, INC.   |  FOG PHARMACEUTICALS, INC.
BARBARA 
 
WEBER 
DIRECTOR
REVOLUTION MEDICINES, INC.   |  FOG PHARMACEUTICALS, INC.   |  TANGO THERAPEUTICS, INC.
KRISHNA 
 
YESHWANT 
DIRECTOR
IPIERIAN, INC.   |  FOUNDATION MEDICINE, INC.   |  1LIFE HEALTHCARE INC   |  DNANEXUS, INC.   |  ELEMENT SCIENCE, INC.   |  FLATIRON HEALTH, INC.   |  PATIENTPING, INC.   |  QUARTET HEALTH, INC.   |  LIFEMINE THERAPEUTICS, INC.   |  FOG PHARMACEUTICALS, INC.   |  VERVE THERAPEUTICS, INC.   |  SPOTLIGHT THERAPEUTICS, INC.   |  QUARTET HEALTH HOLDINGS, INC.
WEIQING 
 
ZHOU 
EXECUTIVE OFFICER
FOG PHARMACEUTICALS, INC.   |  LIFEMINE THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-12-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-17 
2021-01-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-22 
2018-05-16
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-02-02 
2018-02-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-02-02 
2017-08-22
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-05-25 
2016-06-07
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-05-25 
2015-11-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2015-11-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#